Cancer Treatment News and Research

RSS

Synta completes GALAXY-2 trial evaluating ganetespib inhibitor in non-small cell lung cance

Synta Pharmaceuticals Corp. announced today that the first patients have been treated in the randomized GALAXY-2 Phase 3 trial designed to evaluate docetaxel plus ganetespib, its investigational Hsp90 inhibitor, versus docetaxel alone for the second-line treatment of non-small cell lung adenocarcinoma.

22 Apr 2013

Study examines link between cognitive complaints and neuropsychological testing abnormalities in breast cancer patients

For many years, breast cancer patients have reported experiencing difficulties with memory, concentration and other cognitive functions following cancer treatment. Whether this mental "fogginess" is psychosomatic or reflects underlying changes in brain function has been a bone of contention among scientists and physicians.

20 Apr 2013

Highlights: Local Kan. program seeks to prevent readmissions with food deliveries; Conn. officials want stricter limit on insurer markup

A selection of health policy stories from Kansas, Connecticut, Oregon, the District of Columbia, Texas, Florida, Minnesota and California.

20 Apr 2013

First Edition: April 19, 2013

Today's headlines include reports about a new plan by the Bipartisan Policy Center to reduce health spending released.

19 Apr 2013

Researchers find potential new genetic chemotherapy approach for cancer treatment

Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment that could significantly reduce side effects and the development of treatment resistance compared with traditional chemotherapy.

18 Apr 2013

Montreal scientists identify potential target to reduce progression of metastases in breast cancer patients

A team of researchers at the IRCM, led by Dr. Jean Franois Ct, made an important discovery in breast cancer, which will published online this week by the scientific journal Proceedings of the National Academy of Sciences (PNAS).

16 Apr 2013

Research: Gene expression signature may increase risk of tumor recurrence or spread prostate cancer

A team led by Massachusetts General Hospital researchers has identified a genetic signature that appears to reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer.

16 Apr 2013

Study reports 41% reduction in colorectal mortality rates for African Americans

A study analyzing the impact of the Delaware Cancer Consortium, the state's cancer control program, reports a 41 percent reduction in colorectal mortality rates for African Americans.

16 Apr 2013

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Recently, doctors have begun to categorize breast cancers into four main groups according to the genetic makeup of the cancer cells. Which category a cancer falls into generally determines the best method of treatment.

16 Apr 2013

Roundup: Ariz. gov. vetoes bill that would require docs to post prices online, long-term care costs soar in Virginia

Gov. Jan Brewer vetoed legislation Friday that would have required doctors, hospitals and other health care providers to post prices for their most common services, a move the bill's sponsor said was a blow to consumers and driven by industry pressure.

16 Apr 2013

Michigan's first cardio-oncology clinic launched to prevent heart problems

As cancer therapy becomes more effective and the number of cancer survivors increases, doctors are faced with a new challenge: ensuring patients have a healthy heart to enjoy the rest of their lives.

16 Apr 2013

Protein helps leukemia cells avoid effects of chemotherapy by appearing dormant

A new study on how the progression of acute lymphocytic leukemia is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer.

16 Apr 2013

Drug makers must change R&D practices or patent disputes will continue

"[T]he impact of [a decision by the Supreme Court in India to disallow a new patent for an updated version of Novartis' cancer drug Glivec] will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets," Thomas Bollyky, senior fellow for global health, economics, and development at the Council on Foreign Relations and an adjunct professor of law at Georgetown University, writes in an Atlantic opinion piece.

15 Apr 2013

FDA clears Elekta's Versa HD radiation therapy system

Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.

From Elekta 12 Apr 2013

UT MD Anderson scientist receives AACR-CRI Lloyd J. Old Award in Cancer Immunology

The scientist whose discoveries led to the first drug approved for metastatic melanoma by "treating the immune system, not the cancer," also is the first to receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology.

12 Apr 2013

New study shows some women don't stick to recommended treatment for breast cancer

One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.

10 Apr 2013

MD Anderson scientists demonstrate new way to restore tumor suppression

Tumor suppression, the family business of the sibling genes p53, p63 and p73, is undermined from within by the split personalities of p63 and p73, which each produce protein forms that not only block the work of the other two genes but also shut down its own cancer-stifling fraternal twin.

10 Apr 2013

CvergenX to develop radiosensitivity test to better radiation therapy decisions for patients with cancer

A molecular signature index technology that can lead to better radiation therapy decisions for patients with cancer is being developed into a reliable radiosensitivity test by CvergenX, Inc., an advanced cancer diagnostics company.

10 Apr 2013

Gene variations can predispose people to chemotherapy-induced peripheral neuropathy

Seemingly benign differences in genetic code from one person to the next could influence who develops side effects to chemotherapy, a Mayo Clinic study has found.

10 Apr 2013

Nano-sized EVs play role in cancer growth and survival

The recent discovery of circulating "nano-sized extracellular vesicles" (EVs) carrying proteins and nucleic acids derived from brain tumors may lead to exciting new avenues for brain cancer diagnosis, monitoring, and treatment, according to a special article in the April issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

9 Apr 2013

Cancer Treatment News and Research

Synta completes GALAXY-2 trial evaluating ganetespib inhibitor in non-small cell lung cance

Study examines link between cognitive complaints and neuropsychological testing abnormalities in breast cancer patients

Highlights: Local Kan. program seeks to prevent readmissions with food deliveries; Conn. officials want stricter limit on insurer markup

First Edition: April 19, 2013

Researchers find potential new genetic chemotherapy approach for cancer treatment

Montreal scientists identify potential target to reduce progression of metastases in breast cancer patients

Research: Gene expression signature may increase risk of tumor recurrence or spread prostate cancer

Study reports 41% reduction in colorectal mortality rates for African Americans

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Roundup: Ariz. gov. vetoes bill that would require docs to post prices online, long-term care costs soar in Virginia

Michigan's first cardio-oncology clinic launched to prevent heart problems

Protein helps leukemia cells avoid effects of chemotherapy by appearing dormant

Drug makers must change R&D practices or patent disputes will continue

FDA clears Elekta's Versa HD radiation therapy system

UT MD Anderson scientist receives AACR-CRI Lloyd J. Old Award in Cancer Immunology

New study shows some women don't stick to recommended treatment for breast cancer

MD Anderson scientists demonstrate new way to restore tumor suppression

CvergenX to develop radiosensitivity test to better radiation therapy decisions for patients with cancer

Gene variations can predispose people to chemotherapy-induced peripheral neuropathy

Nano-sized EVs play role in cancer growth and survival

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News